List of main publications
2024
Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis. Boué A, Joly F, Lequesne J, Lange M. Cancer. 2024 Feb 2. doi: 10.1002/cncr.35210. Online ahead of print.PMID: 38306301
2023
Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol. Elia C, de Girolamo L, Clarisse B, Galin M, Rehel S, Clochon P, Doidy F, Segobin S, Viader F, Naveau M, Delcroix N, Segura-Djezzar C, Grellard JM, Lequesne J, Etard O, Martin T, Quarck G, Eustache F, Joly F, Giffard B, Perrier J. BMC Cancer. 2023 Dec 1;23(1):1178. doi: 10.1186/s12885-023-11664-x. PMID: 38041077; PMCID: PMC10693085.
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study. Duivon M, Lange M, Binarelli G, Lefel J, Hardy-Léger I, Kiasuwa-Mbengi R, Méric JB, Charles C, Joly F. J Cancer Surviv. 2023 Nov 7.
2022
A Panax quinquefolius-Based Preparation Prevents the Impact of 5-FU on Activity/Exploration Behaviors and Not on Cognitive Functions Mitigating Gut Microbiota and Inflammation in Mice. Parment R, Dubois M, Desrues L, Mutel A, Dembélé KP, Belin N, Tron L, Guérin C, Coëffier M, Compère V, Féger C, Joly F, Hilber P, Ribet D, Castel H. Cancers (Basel). 2022 Sep 10;14(18):4403. doi: 10.3390/cancers14184403.
Functional connectivity correlates of attentional networks in insomnia disorder: A pilot study. Perrier J, Bruijel J, Naveau M, Ramautar J, Delcroix N, Coppens J, Lakbila-Kamal O, Stoffers D, Bessot N, Van Someren EJW.J Sleep Res. 2022 Nov 27;e13796. doi: 10.1111/jsr.13796.
Editorial: Sleep and circadian rhythms in cancer patients and their relationship with quality of life. Perrier J, Giffard B, Wu LM, Savard J, Amidi A. Front Neurosci. 2022 Nov 28;16:1060184. doi: 10.3389/fnins.2022.1060184. eCollection 2022.
Cognitive change in breast cancer patients up to 2 years after diagnosis. J Natl Cancer Inst. 2022 Dec 26:djac240. doi: 10.1093/jnci/djac240. Online ahead of print.
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial. Lange M, Clarisse B, Leconte A, Dembélé KP, Lequesne J, Nicola C, Dubois M, Derues L, Gidron Y, Castel H, Joly F.BMC Cancer. 2022 Dec 13;22(1):1308. doi: 10.1186/s12885-022-10384-y.
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe. European Cancer and Cognition Consortium (ECCC), Sleurs C, Amidi A, Wu LM, Kiesl D, Zimmer P, Lange M, Rogiers A, Giffard B, Binarelli G, Borghgraef C, Deprez S, Duivon M, De Ruiter M, Schagen S, Ahmed-Lecheheb D, Castel H, Buskbjerg CR, Dos Santos M, Joly F, Perrier J. Crit Rev Oncol Hematol. 2022 Oct 17;180:103859.
Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task. Duivon M, Perrier J, Segura-Djezzar C, Joly F, Rehel S, Berthomier C, Grellard JM, Clarisse B, Geffrelot J, Emile G, Lévy C, Viader F, Eustache F, Desgranges B, Rauchs G, Giffard B. Front Neurosci. 2022 Sep 7;16:908268.
Sleep macro- and microstructure in breast cancer survivors. Perrier J, Duivon M, Clochon P, Rehel S, Doidy F, Grellard JM, Segura-Djezzar C, Geffrelot J, Emile G, Allouache D, Levy C, Polvent S, Viader F, Eustache F, Joly F, Giffard B. Sci Rep. 2022 Feb 15;12(1):2557.
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, Cohen HJ, Graham D, Extermann M, Heutte N, Jim HSL, McDonald BC, Patel SK, Root JC, Saykin AJ, Van Dyk K, Zhou X, Mandelblatt J, Joly F; Thinking Living with Cancer C. O. G.-Age Studies. Breast Cancer Res Treat. 2022 Jan;191(2):459-469.
2021
Thinking Living with Cancer C. O. G.-Age Studies. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, Cohen HJ, Graham D, Extermann M, Heutte N, Jim HSL, McDonald BC, Patel SK, Root JC, Saykin AJ, Van Dyk K, Zhou X, Mandelblatt J, Joly F. Breast Cancer Res Treat. 2021 Nov 24. doi: 10.1007/s10549-021-06455-6. Epub ahead of print. PMID: 34817750.
Are Sleep Complaints Related to Cognitive Functioning in Non-Central Nervous System Cancer? A Systematic Review. Duivon, M., Giffard, B., Desgranges, B., & Perrier, J. (2021). Neuropsychology Review. https://doi.org/10.1007/s11065-021-09521-4
Rest activity rhythms characteristics of breast cancer women following endocrine therapy. Martin, T., Duivon, M., Bessot, N., Grellard, J. M., Emile, G., Polvent, S., Raoul, L., Viader, F., Eustache, F., Joly, F., Giffard, B., & Perrier, J. (2021). Sleep, zsab248. https://doi.org/10.1093 /sleep/zsab248
Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult cancer patients in day-care hospital. Florence Joly, Olivier Rigal, Lydia Guittet, Sophie LefèvreArbogast, Jean-Michel Grellard, Giulia Binarelli, Marie Lange, Chantal Rieux, Marie Fernette, Laure Tron, François Gernier, Romain Travers, Adeline Morel, Doriane Richard, Bénédicte Griffon, Alexandra Leconte, Etienne Bastien, Florian Quilan, Louis-Ferdinand Pépin, Fabrice Jardin, Marianne Leheurteur, Bénédicte Clarisse, Justine Lequesne, Audrey Faveyrial. Cancer 2021 10.1002/cncr.33856
Multimodal Web-Based Intervention for Cancer-Related Cognitive Impairment in Breast Cancer Patients: Cog-Stim Feasibility Study Protocol. Binarelli G, Lange M, Dos Santos M, Grellard JM, Lelaidier A, Tron L, Lefevre Arbogast S, Clarisse B, Joly F. Cancers (Basel). 2021 Sep 28;13(19):4868. doi: 10.3390/cancers13194868. PMID: 34638354; PMCID: PMC8508392.
Management of Cancer-Related Cognitive Impairment: A Systematic Review of Computerized Cognitive Stimulation and Computerized Physical Activity. Binarelli G, Joly F, Tron L, Lefevre Arbogast S, Lange M. Cancers (Basel). 2021 Oct 14;13(20):5161. doi: 10.3390/cancers13205161. PMID: 34680310; PMCID: PMC8534081.
The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice. Nicola C, Dubois M, Campart C, Al Sagheer T, Desrues L, Schapman D, Galas L, Lange M, Joly F, Castel H. Cancers. 2021; 13(14):3518. https://doi.org/10.3390/cancers13143518
Geriatric phone follow-up including validated cognitive assessment in older patients treated for cancer. Marie Lange, Giulia Binarelli, Florence Joly. Journal of Geriatric Oncology, 2021, ISSN 1879-4068, https://doi.org/10.1016/j.jgo.2021.01.005.
Le sommeil dans les cancers non cérébraux : revue de la littérature, mécanismes potentiels et perspectives pour mieux comprendre les troubles cognitifs associés, J. Perrier, M. Duivon, G. Rauchs, B. Giffard, Médecine du Sommeil, Volume 18, Issue 2, 2021, Pages 90-103, ISSN 1769-4493, https://doi.org/10.1016/j.msom.2020.12.002.
2020
Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub-study of the French CANTO cohort. Hardy-Leger I, Charles C, Lange M, Joly F, Roux P, Capel A, Petrucci J, Rigal O, Fel JL, Vanlemmens L, Everhard S, Anne-Laure M, Vaz Luis I, Coutant C, Cottu P, Levy C, Lerebours F, Andre F, Licaj I, Dauchy S. Psychooncology. 2020 Oct 14. doi: 10.1002/pon.5572. Epub ahead of print. PMID: 33052613.
Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors. Boscher C, Joly F, Clarisse B, Humbert X, Grellard JM, Binarelli G, Tron L, Licaj I, Lange M. Cancers (Basel). 2020 Oct 16;12(10):E3000. doi: 10.3390/cancers12103000. PMID: 33081111.
Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup. Lange M, Hardy-Léger I, Licaj I, Pistilli B, Rigal O, Le Fel J, Lévy C, Capel A, Coutant C, Meyer J, Lerebours F, Petrucci J, Vanlemmens L, Brion M, Campone M, Soulié P, Blain M, Vaz-Luis I, Giffard B, Martin AL, Everhard S, André F, Dauchy S, Joly F. Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1759-1766. doi: 10.1158/1055-9965.EPI-20-0346. Epub 2020 Jul 1. PMID: 32611581.
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial. Dos Santos M, Hardy-Léger I, Rigal O, Licaj I, Dauchy S, Levy C, Noal S, Segura C, Delcambre C, Allouache D, Parzy A, Barriere J, Petit T, Lange M, Capel A, Clarisse B, Grellard JM, Lefel J, Joly F. Cancer. 2020 Sep 30. doi: 10.1002/cncr.33186. Epub ahead of print. PMID: 32996583.
Immunothérapies du cancer : quel impact sur les fonctions cognitives ? [Immunotherapies of cancer: Is there any impact on patient cognitive functions?]. Castel H, Joly F. Med Sci (Paris). 2020 Aug-Sep;36(8-9):695-699. French. doi: 10.1051/medsci/2020139. Epub 2020 Aug 21. PMID: 32821042.
The role of metamemory on cognitive complaints in cancer patients. Giffard B, Perrotin A, Allain P, Dayan J, Eustache F, Grellard JM, Faveyrial A, Joly F, Lange M. Brain Behav. 2020 Mar 10:e01545. doi: 10.1002/brb3.1545. [Epub ahead of print] PubMed PMID: 32154659.
Impact psychologique de l’épidémie de Covid-19 et du confinement chez des patients pris en charge pour un cancer. Giffard B, Joly F. Rev Neuropsychol 2020 ; 12 (2) : 193-5 doi:10.1684/nrp.2020.0569
2019
Quelle est la plainte cognitive des patients traités pour un cancer (hors système nerveux central) ? Florence Joly. Revue de neuropsychologie.2019;11(4):294-295. doi:10.1684/nrp.2019.0530.
Long-term fatigue and cognitive disorders in breast cancer survivors. Florence Joly, Marie Lange, Mélanie Dos Santos, Ines Vaz-Luiz, Antonio Di-Meglio. Cancers (Basel), Special Issue “Treatment Strategies and Survival Outcomes in Breast Cancer” (accepted)
Cancer-Related Cognitive Impairment: An update on state of the art, detection, and management strategies in cancer survivors. Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, De Ruiter MB, Castel H. Ann Oncol. 2019 Oct 16.pii: mdz410. doi: 10.1093/annonc/mdz410. [Epub ahead of print] PubMed PMID:31617564.
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer. Lange M, Castel H, Le Fel J, Tron L, Maillet D, Bernaudin M, Touzani O, Perrier J, Boone M, Licaj I, Giffard B, Dubois M, Rigal O, Durand T, Belin C, Ricard D, Le Gal R, Pancré V, Hardy-Léger I, Joly F. Neurosci Biobehav Rev. 2019 Sep 22. pii: S0149-7634(19)30478-6. doi:10.1016/j.neubiorev.2019.09.028. [Epub ahead of print] Review. PubMed PMID:31553925.
Potential impact of immunotherapy agents on cognitive function in cancer patients. Joly F, Castel H, Tron L, Lange M, Vardy J. J Natl Cancer Inst. 2019 Aug 26. pii: djz168. doi: 10.1093/jnci/djz168. [Epub ahead of print] PubMed PMID:31504664.
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol (2019). Paul Lesueur, Justine Lequesne, Jean-Michel Grellard, Audrey Dugué, Elodie Coquan, Pierre-Emmanuel Brachet Julien Geffrelot, Evelyne Emery, Hassanein Berro, Laurent Castera, Nicolas Goardon, Joëlle Lacroix, Marie Lange, Aurélie Capel, Alexandra Leconte, Benoit Andre, Angélique Léger, Anais Lelaidier , Bénédicte Clarisse, Dinu Stefan. BMC Cancer, 19(1):198. doi: 10.1186/s12885-019-5413-y.
Cognitive complaints in cancer survivors and expectations for support: Results from a web-based survey. Lange M, Licaj I, Clarisse B, Humbert X, Grellard JM, Tron L, Joly F. Cancer Med. 2019 Mar 18. doi: 10.1002/cam4.2069. [Epub ahead of print] PubMed PMID: 30884207.
Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence. Dos Santos M, Lange M, Gervais R, Clarisse B, Capel A, Barillet M, Grellard JM, Heutte N, Licaj I, Joly F. Support Care Cancer. 2019 Jan 28. doi: 10.1007/s00520-019-4644-4. [Epub ahead of print] PubMed PMID: 30690685.
Neuropsychologie des traumatismes : comprendre, faire face, aider. Giffard B., Eustache F. Revue de neuropsychologie (2019), 11(4), 247-249. doi:10.1684/nrp.2019.0532.
2018
Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level. Perrier J, Viard A, Levy C, Morel N, Allouache D, Noal S, Joly F, Eustache F, Giffard B. Brain Imaging Behav. 2018 Nov 7. doi: 10.1007/s11682-018-9991-0. [Epub ahead of print] PubMed PMID: 30406352.
Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study. Duivon M, Perrier J, Joly F, Licaj I, Grellard JM, Clarisse B, Lévy C, Fleury P, Madeleine S, Lefèvre N, Rauchs G, Lecouvey G, Fraisse F, Viader F, Eustache F, Desgranges B, Giffard B. BMC Cancer. 2018 Sep 3;18(1):866. doi:10.1186/s12885-018-4762-2. PubMed PMID: 30176833; PubMed Central PMCID:PMC6122719.
[Actualités sur la plainte cognitive associée au cancer du sein : la mémoire prospective, une mémoire oubliée.] Duivon M, Perrier J, Desgranges B, Giffard B (2018). Rev Neuropsychol, 10 (3) : 222-31.
Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology. Rambeau A, Beauplet B, Laviec H, Licaj I, Leconte A, Chatel C, Le Bon P, Denhaerynck J, Clarisse B, Frenkiel N, Lange M, Joly F. J Geriatr Oncol. 2018 Aug 24. pii: S1879-4068(18)30095-X. doi: 10.1016/j.jgo.2018.08.003. [Epub ahead of print] PubMed PMID: 30150019
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. Lange M, Heutte N, Noal S, Rigal O, Kurtz JE, Lévy C, Allouache D, Rieux C, Lefel J, Clarisse B, Leconte A, Veyret C, Barthélémy P, Longato N, Tron L, Castel H, Eustache F, Giffard B, Joly F. The Oncologist. 2018 Jun 22. pii: theoncologist.2017-0570. doi: 10.1634/theoncologist.2017-0570. [Epub ahead of print] PubMed PMID: 29934409.
Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research. Winocur G, Johnston I, Castel H. Cancer Treat Rev. 2018 Jun 1;69:72-83. doi: 10.1016/j.ctrv.2018.05.017. [Epub ahead of print] Review. PubMed PMID: 29909223.
Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies. Denouel A, Heutte N, Escudier B, Kurtz JE, Santos MD, Longato N, Desrues L, Dauchy S, Lange M, Sevin E, Rieux C, Clarisse B, Castel H, Noal S, Joly F. Clin Genitourin Cancer.2018 May 21. pii:
S1558-7673(18)30286-6. doi: 10.1016/j.clgc.2018.05.013. [Epub ahead of print] PubMed PMID: 30007862.
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. Lange M, Laviec H, Castel H, Heutte N, Leconte A, Léger I, Giffard B, Capel A, Dubois M, Clarisse B, Coquan E, Di Fiore F, Gouérant S, Bartélémy P, Pierard L, Fizazi K, Joly F. BMC Cancer. 2018 Jan 30;18(1):110. doi: 10.1186/s12885-017-3764-9. PubMed PMID: 29382311; PubMed Central PMCID: PMC5791194.
2017
How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment. Lange M, Joly F. J Oncol Pract. 2017 Dec;13(12):784-790. doi:10.1200/JOP.2017.026286. PubMed PMID: 29232539.
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. Lange M, Laviec H, Castel H, Heutte N, Leconte A, Leger I, et al. BMC Cancer. 2017;17(1):549.
Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors. Castel, H., Denouel, A., Lange, M., Tonon, M-C., Dubois, M., Joly, F. (2017).Frontiers in Pharmacology, 8: 138
[Cognitive complaints induced by cancer treatments in oncology]. Lange, M., Léger, I. La lettre du Cancérologue Vol. XXVI – n° 4 – avril 2017
Cognitive complaints in breast cancer patients treated with chemotherapy: a reality? Lange M, Joly F. Transl Cancer Res 2017;6(Suppl 3):S461-S463. doi: 10.21037
Influence of depressive symptoms on memory in transient global amnesia. Noel A, Quinette P, Dayan J, de La Sayette V, Viader F, Desgranges B, Giffard B, Eustache F. J Neuropsychol 2017; 11:108-121. DOI: 1111/jnp.12080
2016
Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Lange M., Heutte N., Rigal O., Noal S, Kurtz J-E., Lévy C., Allouache D., Rieux C., Lefel J., Clarisse B., Veyret C., Barthélémy P., Longato N., Eustache F., Giffard B., Joly F. The Oncologist. 2016; 21(11), 1337-1348.
Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer. Joly F., Heutte N., Duclos B., Noal S., Léger I., Dauchy S., Longato N., Desrues L., Houédé N., Lange M., Sevin E., Rieux C., Clarisse B., Castel H., Escudier B. European Urology Focus. 2016, 2(6), 642-649http://dx.doi.org/10.1016/j.euf.2016.04.009
2015
Impact of cancer and treatments on cognitive functions: Advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since then. Joly F., Giffard B., Rigal O., De Ruiter M.B., Small B.J. Dubois M., LeFel J., Schagen S.B., Ahles T.A. Wefel J.S., Vardy J.L. Pancré V., Lange M., Castel H. J Pain Symptom Manage. 2015; 50(6), 830-841.
Emotional specificities of autobiographical memory after breast cancer diagnosis. Morel N., Dayan J., Piolino P., Viard A., Allouache D., Noal S., Levy C., Joly F., Eustache F., Giffard B. Consciousness and Cognition 2015 Sept; 35, 42-52.
Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population. Lange M., Heutte N., Morel N., Eustache F., Joly F., Giffard B. Neuropsychol Rehabil. 2015 May 7:1-18.
[Mild cognitive deficits in cancer: their clinical assessment and management]. Giffard, B., Lange, M., Léger, L. Revue de neuropsychologie. 2015, 7(2), 127-134.
2014
Monitoring and optimising cognitive functioning cancer patients: Present knowledge and future directions. Schagen S.B., Klein M., Reijneveld J.C., Brain E., Deprez S., Joly F., Scherwath A., Schrauwen W., Wefel J.S.. EJC Supplements 2014: 29–40.
Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Lange M., Rigal O., Clarisse B., Giffard B., Sevin E., Barillet M., Eustache F., Joly F. Cancer Treatment Rev 2014 Jul; 40(6):810-7.
Baseline cognitive functions among elderly patients with localized breast cancer. Lange M., Giffard B., Noal S., Rigal O., Kurtz J-E., Heutte N., Lévy C., Allouache D., Rieux C., Lefel J., Daireaux A., Clarisse B., Veyret C., Barthélémy P., Longato N., Eustache F., Joly F. Eur J Cancer. 2014 Sep; 50(13):2181-9.
Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant. Dubois M., Lapinte N., Villier V., Lecointre C., Roy V., Tonon MC., Gandolfo P., Joly F., Hilber P., Castel H. Neuropharmacology. 2014; 79:234-48.
Evaluation of the impact of the cancer therapy everolimus on the central nervous system in mice. Dubois M., Le Joncour V., Tonon MC., Anouar Y., Proust F., Morin F., Gandolfo P., Joly F., Hilber P., Castel H. PLoS One. 2014;1;9-12.
2013
[Impact of cancer treatments on cognitive functions: the patients’ view, their expectation and their interest in participating to cognitive rehabilitation workshops]. Le Fel J., Daireaux A., Vandenbosshe S., Heutte N., Rigal O., Rovira K., Joly F,. Roy V. Bull Cancer. 2013 ;100 (3):223-9.
Autobiographical memory, self, and stress-related psychiatric disorders: which implications in cancer patients? Giffard B., Viard A., Dayan J., Morel N., Joly F., Eustache F. Neuropsychol Rev. 2013;23 157-68.
Impact of antiangiogenic treatment on cognitive functions and fatigue in metastatic renal cancer patients. Joly F., Noal S., Heutte N., Leger I., Duclos B., Lange M., Longato N., Dauchy S., Clarisse B., Escudier B. ESMO congress, Amsterdam sept 2013.
[A memory consultation in oncology: between complaint and disorder…]. Léger I., de Batz L., Dauchy S. Psycho-Oncologie. 2013, 7, 210-216.
Synthesis, Biological Evaluation, and in Vivo Imaging of the first Camptothecin-Fluorescein Conjugate. Chevalier A., Dubois M., Le Joncour V., Dautrey S., Lecointre C., Romieu A., Renard PY., Castel H., Sabot C. Bioconjug Chem. 2013 Jun 24.
2012
French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Joly F., Lange M., Rigal O., Correia H., Giffard B., Beaumont JL., Clisant S., Wagner L. Support Care Cancer. 2012; 20:3297-305.
2011
Cognitive dysfunction and cancer: which consequences in terms of disease management? Joly F., Rigal O., Noal S., Giffard B. Psychooncology. 2011 Dec;20(12):1251-8.
One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Noal S., Levy C., Hardouin A., Rieux C., Heutte N., Ségura C., Collet F., Allouache D., Switsers O., Delcambre C., Delozier T., Henry-Amar M., Joly F. Int J Radiat Oncol Biol Phys. 2011 Nov 1; 81(3):795-803.
[Impact of adjuvant chemotherapy on cognitive functions in breast cancer: literature review]. Lange M., Giffard B., Eustache F., Morel N., Noal S. & Joly F. Psycho-oncologie, 2011; 5(1), 3-10.
2010
[The impact of cancer and its treatment on cognitive function: the example of breast cancer]. Morel N., Eustache F., Lange M., Joly F., Giffard B. Revue de neuropsychologie 2010: 2(3), 250 – 254.
2008
[Cognitive functions and cancer]. Joly.F. Bull Cancer 2008 ; 95 (11) : 1131-2